Table 2.
The comparison of baseline characteristics of all patients by group.
| Variables | Classification | low-risk groups (n= 155) n (%) | high-risk groups (n=53) n (%) | P-value |
|---|---|---|---|---|
| Gender | Female Male |
129(83.226) 26(16.774) |
48(90.566) 5(9.434) |
0.195 |
| Age (years) | <25 ≥25 |
50(32.258) 105(67.742) |
24(45.283) 29(54.717) |
0.087 |
| Symptomatic | - + |
84(54. 194) 71(45.806) |
7(13.208) 46(86.792) |
<0.001 |
| The maximum diameter (cm) | <7.2 ≥7.2 |
109(70.323) 46(29.677) |
21(39.623) 32(60.377) |
<0.001 |
| Location | Head Neck Body Tail |
36(23.226) 19(12.258) 39(25. 161) 61(39.355) |
10(18.868) 12(22.642) 8(15.094) 23(43.396) |
0.163 |
| Margin | Clear Not Clear |
98(63.226) 57(36.774) |
15(28.302) 38(71.698) |
<0.001 |
| Calcification | - + |
61(39.355) 94(60.645) |
16(30. 189) 37(69.811) |
0.233 |
| Capsule | Complete Incomplete |
102(65.806) 53(34. 194) |
15(28.302) 38(71.698) |
<0.001 |
| Distal pancreatic atrophy | No Yes |
110(70.968) 45(29.032) |
45(84.906) 8(15.094) |
0.044 |
| Pancreatic and bile duct dilation | No Yes |
116(74.839) 39(25. 161) |
36(67.925) 17(32.075) |
0.327 |
| Tumor markers | - + |
139(89.677) 16(10.323) |
44(83.019) 9(16.981) |
0.198 |
| Viral hepatitis | - + |
149(96. 129) 6(3.871) |
48(90.566) 5(9.434) |
0.118 |
| NLR | <1.54 ≥1.54 |
63(40.645) 92(59.355) |
15(28.302) 38(71.698) |
0.109 |
| PLR | <117.7 ≥117.7 |
50(32.258) 105(67.742) |
24(45.283) 29(54.717) |
0.087 |
| SII | <781.44 ≥781.44 |
129(83.226) 26(16.774) |
38(71.698) 15(28.302) |
0.069 |
| PNI | <47.45 ≥47.45 |
24(15.484) 131(84.516) |
22(41.509) 31(58.491) |
<0.001 |
| LMR | <5.519 ≥5.519 |
86(55.484) 69(44.516) |
38(71.698) 15(28.302) |
0.038 |
| SIRI | <5.23 ≥5.23 |
127(81.935) 28(18.065) |
35(66.038) 18(33.962) |
0.016 |
| ki67, n (%) | ≤3% 3-5% ≥5% |
130(83.871) 12(7.742) 13(8.387) |
40(75.472) 7(13.208) 6(11.321) |
0.367 |
+, yes; −, no; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; SII, systemic immune-inflammation index; LMR, lymphocyte-to-monocyte ratio; SIRI, systemic inflammatory response index; PNI, prognostic nutritional index.